Pfizer Hospira

In this May 4, 2014 file photo, the Pfizer logo is displayed on the exterior of a former Pfizer factory in the Brooklyn borough of New York. Pfizer is buying Hospira for approximately $15.23 billion, saying it is a good fit with its global established pharmaceutical business. Hospira Inc., based in Lake Forest, Illinois, is a provider of injectable drugs and infusion technologies. Pfizer said Thursday, Feb. 5, 2015 that it will use its global network to help expand Hospira’s reach to Europe and key emerging markets. (AP Photo/Mark Lennihan)

Leave a Comment